Search

Learn about the latest guidelines for Pap tests, HPV tests, and pelvic exams — including recently updated recommendations.

… Thursday, February 14, 2019 Summary An MSK expert explains the recently updated recommendations for Pap tests, HPV tests, and pelvic exams. Regular screenings play a vital role in helping women prevent cervical cancer , which used to be one of the most common causes of death for women in the United States

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.

… Tuesday, September 25, 2018 Summary Gynecologist Deborah Goldfrank shares the facts about how hormonal birth control can affect a woman’s risk for cancer. When it comes to cancer risk, birth control sometimes gets a bad rap. “Usually when we talk about birth control and cancer, we’re talking about the

MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.

… Wednesday, August 21, 2019 Summary A new study from Memorial Sloan Kettering reports the first evidence of a bacterial species that appears to help kill dangerous microbes in the gut. Hospital-acquired infections are a major threat, especially for people whose immune systems may be compromised because

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

… Friday, April 20, 2012 Summary In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok. In

Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.

… Friday, April 1, 2011 Summary Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University. Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomes 21 students to the Summer Undergraduate Research Program.

… Friday, May 26, 2017 The 2017 Summer Undergraduate Research Program (SURP) began with the arrival of 21 undergraduate students, under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s SURP class includes 13 women and eight men, all of whom are undergraduates

Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.

… Friday, January 10, 2025 Adrienne Boire, MD, PhD , has been a knitter almost her entire life. In the famously frigid plains of Minnesota, where Dr. Boire grew up, knitting is taught as part of regular elementary education. It’s a way to make math fun for kids, teach concentration skills, and let them

MSK investigators have shown that a gene mutation linked to many kinds of cancer can also cause birth defects of the nervous system.

… Friday, February 26, 2016 Summary MSK investigators have shown that a mutation in a gene called PTEN that’s linked to many kinds of cancer can also cause birth defects of the nervous system. Their research unveils the mechanism by which the mutation affects cell shape and prevents cells from properly

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in Health Affairs on February 6, 2017, and to speak with the study author, contact [email protected].

… Tuesday, February 7, 2017 Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis.  Job loss can have devastating financial consequences, including increased risk

As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu.

… Monday, November 16, 2020 As flu season ramps up amid the continuing uncertainty of the COVID-19 pandemic, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the risks and what precautions they could take to safeguard against the flu this year. The